Invst LLC Purchases Shares of 14,582 Omega Healthcare Investors, Inc. $OHI

Invst LLC purchased a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 14,582 shares of the real estate investment trust’s stock, valued at approximately $695,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Omega Healthcare Investors during the second quarter worth approximately $1,838,155,000. Bank of New York Mellon Corp purchased a new stake in shares of Omega Healthcare Investors in the 2nd quarter valued at $275,230,000. Norges Bank purchased a new stake in shares of Omega Healthcare Investors in the 4th quarter valued at $156,166,000. Invesco Ltd. grew its holdings in shares of Omega Healthcare Investors by 101.7% during the 3rd quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock valued at $208,775,000 after purchasing an additional 2,493,877 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Omega Healthcare Investors during the 4th quarter valued at $93,476,000. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Stock Performance

Shares of Omega Healthcare Investors stock opened at $46.92 on Wednesday. Omega Healthcare Investors, Inc. has a 52-week low of $39.26 and a 52-week high of $52.39. The company’s 50 day moving average price is $48.24 and its 200-day moving average price is $47.08. The stock has a market capitalization of $14.22 billion, a price-to-earnings ratio of 16.76, a P/E/G ratio of 1.88 and a beta of 0.57.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.68. The company had revenue of $328.25 million during the quarter, compared to analyst estimates of $266.97 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The firm’s revenue was up 16.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.77 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, equities research analysts forecast that Omega Healthcare Investors, Inc. will post 3.12 earnings per share for the current fiscal year.

Omega Healthcare Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, August 3rd were given a $0.68 dividend. The ex-dividend date was Monday, August 3rd. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.67. This represents a $2.72 dividend on an annualized basis and a dividend yield of 5.8%. Omega Healthcare Investors’s dividend payout ratio is presently 97.14%.

Analyst Ratings Changes

A number of brokerages recently commented on OHI. Citigroup lifted their target price on shares of Omega Healthcare Investors from $52.00 to $58.00 and gave the stock a “buy” rating in a research report on Tuesday, August 4th. Truist Financial cut their price target on shares of Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating for the company in a research report on Tuesday, June 9th. Raymond James Financial assumed coverage on Omega Healthcare Investors in a research note on Tuesday, June 16th. They set an “outperform” rating and a $50.00 price objective on the stock. Royal Bank Of Canada lifted their price objective on Omega Healthcare Investors from $47.00 to $48.00 and gave the stock a “sector perform” rating in a report on Monday, May 4th. Finally, Scotiabank lowered their target price on Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Six equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $49.21.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.